Organoids and Spheroids Market Size

Organoids and Spheroids Market Size

Organoids And Spheroids Market was valued at USD 1.1 billion in 2023 growing at a CAGR of 19.1% between 2024 and 2032, driven by factors such as the increase in demand for personalized medicines, a rise in investments toward R&D activities, and a shift in preference toward organoid 3D cell cultures for cancer research.

To get key market trends

  Download Free Sample

Moreover, the surge in technological advancement in 3D spheroids technologies is expected to boost the market growth. For instance, in July 2023, Molecular Devices, LLC., a leading high-performance life science solutions provider, continues industrializing biology with its organoid line expansion services to support next-generation drug discovery. The offering leverages proprietary bioreactor and bioprocess technology to scale up the production of standardized, assay-ready organoids originating from customer-supplied organoid lines or patient-derived xenografts (PDX).
 

Organoids are complex, self-organizing structures derived from stem cells or tissue-specific progenitor cells. Organoids can be generated from various cells and including pluripotent stem cells or adult tissue-specific stem cells and can recapitulate the cellular diversity and spatial organization found in native tissues. Spheroids are simple aggregates of cells that form rounded, 3D structures in culture. Unlike organoids, which aim to replicate the structural and functional complexity of specific tissues or organs, spheroids are often composed of one or more cell types and lack the tissue-specific organization seen in organoids.